Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
ZVRA · NASDAQ · Pharmaceutical Preparations
$9.40+0.15 (+1.62%)
Close of Nov 17, 2026, vs Nov 16 · end-of-day, not a live quote
Zevra Therapeutics (ZVRA) · oqro.io/stocks/ZVRA · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Oct 12, 2026 · Filed Oct 13, 2026
CEO sold ~$225K of ZVRA shares in the open marketSourcePlanned sale · Planned for Oct 12, 2026 · Notice filed Oct 12, 2026
Officer filed to sell about $228K of ZVRA stockSourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Rubric Capital Management LP no longer reported ZVRA for Q3 2025SourceInsider trade · Traded Sep 12, 2025 · Filed Sep 16, 2025
Director purchased ~$25K of ZVRA shares in the open marketSourceInsider trade · Traded Sep 12, 2025 · Filed Sep 15, 2025
Director purchased ~$158K of ZVRA shares in the open marketSourceInsider trade · Traded Aug 19, 2025 · Filed Aug 20, 2025
Director purchased ~$46K of ZVRA shares in the open marketSourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Rubric Capital Management LP disclosed an increased position in ZVRA for Q2 2025SourceInsider trade · Traded Jun 26, 2025 · Filed Jun 30, 2025
Officer sold ~$221K of ZVRA shares in the open marketSourceInsider trade · Traded Mar 28, 2025 · Filed Apr 1, 2025
Director purchased ~$2.4K of ZVRA shares in the open marketSourceInsider trade · Traded Mar 19, 2025 · Filed Mar 21, 2025
Director purchased ~$80K of ZVRA shares in the open marketSourceInsider trade · Traded Feb 13, 2025 · Filed Feb 14, 2025
CEO sold ~$481K of ZVRA shares in the open marketSourceInsider trade · Traded Feb 14, 2025 · Filed Feb 14, 2025
CEO sold ~$246K of ZVRA shares in the open marketSourceInsider trade · Traded Feb 13, 2025 · Filed Feb 14, 2025
CFO sold ~$86K of ZVRA shares in the open marketSourceInsider trade · Traded Feb 13, 2025 · Filed Feb 14, 2025
Officer sold ~$83K of ZVRA shares in the open marketSourceInsider trade · Traded Oct 11, 2024 · Filed Oct 16, 2024
Director purchased ~$4K of ZVRA shares in the open marketSourceInsider trade · Traded Feb 13, 2025 · Filed Feb 14, 2025
Officer sold ~$24K of ZVRA shares in the open marketSource